March 01, 2007
Genentech sends “dear doctor” letters
Genentech has sent a “dear doctor” letter to warn about a higher risk for stroke in patients taking 0.5 mg of Lucentis, indicated for treating wet age-related macular degeneration.
The government agency released its latest guidance this week.
11 questions for the GW CEO on the watershed moment.
The Office of Prescription Drug Promotion has sent its second warning letter of the year.